IPSC
Century Therapeutics Inc.
Company Overview
| Mkt Cap | $53.54M | Price | $0.58 |
| Volume | 653.05K | Change | -1.50% |
| P/E Ratio | -0.4 | Open | $0.59 |
| Revenue | $6.6M | Prev Close | $0.59 |
| Net Income | $-126.6M | 52W Range | $0.34 - $1.83 |
| Div Yield | N/A | Target | $4.40 |
| Overall | 49 | Value | 60 |
| Quality | 31 | Technical | 58 |
No chart data available
Stock Overview
Updated DailyCentury Therapeutics Inc. (IPSC) is a leading Professional, Scientific, and Technical Services company in the Research and Development in Biotechnology industry, currently trading at $0.58 with a market capitalization of $53.54 million. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating concerning quality fundamentals with a MarketXLS quality score of 31.
Today's trading session shows IPSC with a volume of 653K shares. The stock opened down 0.34% from yesterday's close of $0.59. Current analyst estimates project earnings of $-0.2 per share for this year, with next year targeting $-1.35.
IPSC demonstrates neutral technical outlook based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for IPSC include below-average investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 654.6%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 07:03 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | IPSC | $0.58 | -1.5% | 653.05K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Century Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW